News Medical on MSN
Innovative review reveals overlooked complexity in cellular energy sensor's dual roles in Alzheimer's disease
A mini-review in Brain Medicine examines the distinct and often opposing roles of AMPKα1 and AMPKα2 isoforms in Alzheimer's ...
Pharmaceutical Technology on MSN
Eli Lilly signs $1.3bn obesity-focused research deal with Nimbus
Nimbus will apply its computational chemistry and structure-based drug design to a discovery programme in obesity treatment.
A recent review examined how widely used treatments such as metformin, SGLT2 inhibitors, and GLP-1 receptor agonists may ...
Diabetes medications found to influence cancer growth in unexpected ways What if the drugs millions take for diabetes every ...
Pharma Pulse: Pediatric Vaccine Revisions, COPD Mortality Trends, and Eli Lilly’s $1.3B Obesity Deal
In today’s Pharma Pulse, federal officials slash the childhood immunization schedule, new data underscores the life-saving ...
Nimbus and Eli Lilly collaborate to develop an oral treatment for obesity, leveraging computational chemistry and structure-based drug design. Nimbus Therapeutics and Eli Lilly announce their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback